Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.

Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Schwarz P, Faber J.

Endocrine. 2013 Jun;43(3):626-34. doi: 10.1007/s12020-012-9836-3. Epub 2012 Nov 22.

PMID:
23179776
2.

Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.

Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Flyvbjerg A, Faber J.

Metabolism. 2014 Jan;63(1):141-9. doi: 10.1016/j.metabol.2013.09.017. Epub 2013 Oct 17.

PMID:
24140097
3.

Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.

Doehner W, Pflaum CD, Rauchhaus M, Godsland IF, Egerer K, Cicoira M, Florea VG, Sharma R, Bolger AP, Coats AJ, Anker SD, Strasburger CJ.

Eur J Endocrinol. 2001 Dec;145(6):727-35.

4.

Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.

Siednienko J, Jankowska EA, Banasiak W, Gorczyca WA, Ponikowski P.

Int J Cardiol. 2007 Nov 15;122(2):111-6. Epub 2007 Jan 30.

PMID:
17270295
5.

Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.

Szabó T, Scherbakov N, Sandek A, Kung T, von Haehling S, Lainscak M, Jankowska EA, Rudovich N, Anker SD, Frystyk J, Flyvbjerg A, Pfeiffer AF, Doehner W.

Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):50-6. doi: 10.1016/j.numecd.2013.04.015. Epub 2013 Jun 19.

PMID:
23791298
6.

Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.

Shaikh K, Hanif B, Siddique AA, Shaikh MY, Khan MN.

J Coll Physicians Surg Pak. 2012 Dec;22(12):751-5. doi: 12.2012/JCPSP.751755.

PMID:
23217478
7.

Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure.

Chang HR, Hsieh JC, Hsu BG, Wang LY, Chen MY, Wang JH.

PLoS One. 2013 Nov 12;8(11):e79096. doi: 10.1371/journal.pone.0079096. eCollection 2013.

8.

[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].

Wu YR, Chen SB, Huang MR, Zhang YQ, Sun K, Chen S.

Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4. Chinese.

PMID:
15833183
9.

NT-proBNP, IGF-I and survival in patients with chronic heart failure.

Petretta M, Colao A, Sardu C, Scopacasa F, Marzullo P, Pivonello R, Fontanella L, de Caterina M, de Simone A, Bonaduce D.

Growth Horm IGF Res. 2007 Aug;17(4):288-96. Epub 2007 Mar 23.

PMID:
17383209
10.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr.

Am Heart J. 2005 Apr;149(4):744-50.

PMID:
15990762
11.

Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).

Zhang S, Hu Y, Zhou L, Chen X, Wang Y, Wu J, He H, Gao Y.

Arch Gerontol Geriatr. 2015 Mar-Apr;60(2):359-65. doi: 10.1016/j.archger.2014.11.005. Epub 2014 Nov 25.

PMID:
25466512
12.

The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study.

Tengiz İ, Türk UÖ, Alioğlu E, Kırılmaz B, Tamer GS, Tüzün N, Ercan E.

Anadolu Kardiyol Derg. 2013 May;13(3):221-6. doi: 10.5152/akd.2013.067. Epub 2013 Jan 30.

13.

[Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].

Wang F, Xu ZM, Wang L, Bian WY, Jia X, Duan B, Li W, Li YS.

Zhonghua Nei Ke Za Zhi. 2005 Jul;44(7):490-4. Chinese.

PMID:
16080835
14.

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.

Circulation. 2005 Sep 20;112(12):1756-62. Epub 2005 Sep 12.

15.

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.

Anker SD, Coats AJ.

Chest. 1999 Mar;115(3):836-47. Review.

PMID:
10084500
16.

The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.

Karabulut A, Kaplan A, Aslan C, Iltumur K, Toprak G, Toprak N.

Acta Cardiol. 2005 Dec;60(6):631-8.

PMID:
16385925
17.

[Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].

Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jun;11(6):429-32. Chinese.

PMID:
19558803
18.

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.

Fu S, Xie L, Li D, Ye P, Luo L.

Clin Interv Aging. 2015 Jan 27;10:359-65. doi: 10.2147/CIA.S77417. eCollection 2015.

19.

Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.

Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA.

Circulation. 2009 Jul 7;120(1):35-41. doi: 10.1161/CIRCULATIONAHA.108.824581. Epub 2009 Jun 22.

20.

Association between direct measures of body composition and prognostic factors in chronic heart failure.

Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, Johnson JA, Padwal RS.

Mayo Clin Proc. 2010 Jul;85(7):609-17. doi: 10.4065/mcp.2010.0103.

Supplemental Content

Support Center